Last reviewed: June 4, 2026
Last updated: June 4, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works on a weekly dosing schedule that differs significantly from daily oral medications. Most patients begin at 0.25 mg once per week and gradually move up to a maintenance dose, a process called dose titration that typically spans four to five months and helps your body adapt while minimizing side effects.
Weekly Semaglutide Injection Schedule for Weight Loss
Semaglutide is administered as a subcutaneous injection once every seven days, meaning you inject yourself at the same time each week. This consistent weekly rhythm makes it easy to remember and fits into a predictable routine—many patients choose the same day and time each week to maintain compliance. The medication begins working immediately to reduce hunger signals and slow gastric emptying, two mechanisms that support calorie reduction without requiring constant willpower.
Unlike daily pills that require morning and evening dosing, the weekly injection format delivers a steady therapeutic level throughout the week. This consistency means you experience stable appetite suppression and metabolic benefits without peaks and valleys in drug concentration. The once-weekly schedule also reduces the chance of missed doses compared to daily medications.
Dose Escalation Protocol: Starting Low and Going Slow
The standard semaglutide titration begins at 0.25 mg and increases by 0.25 mg increments every four weeks until reaching your target maintenance dose, usually between 1.0 mg and 2.4 mg weekly. This gradual climb allows your gastrointestinal system and appetite centers to adjust, reducing nausea and other side effects that can occur if the dose rises too quickly. Most patients reach their effective dose within 16 to 20 weeks, at which point they remain stable on that same weekly amount.
Your body's genetic makeup influences how quickly you metabolize semaglutide and how well you respond at each dose level. PlexusDx uses the Precision Peptide Genetic Test to identify variations in your GLP1R and GIPR genes that predict your individual dose requirements and weight loss trajectory. This personalized insight means your dose may climb faster or settle at a lower maintenance level based on your genetics and body composition.
Maintenance Dosing: Staying at Your Effective Level
Once you reach your target maintenance dose—commonly 1.7 mg or 2.4 mg per week—you continue that same injection every seven days as long as you remain on treatment. There is no need to further increase the dose unless your weight loss plateaus or your healthcare provider recommends adjustment based on your progress. Many patients maintain steady weight loss and appetite suppression on their maintenance dose for months or years without dose changes.
PlexusDx monitors your clinical response through regular check-ins and may recommend staying at a lower maintenance dose if you are experiencing satisfactory results and tolerating the medication well. Some patients find their ideal dose is 1.0 mg weekly, while others need 2.4 mg to achieve their goals—this variation is normal and reflects your unique metabolism and genetic factors.
Compounded Semaglutide vs. Brand-Name Ozempic: Dosing Is Identical
PlexusDx offers compounded semaglutide injection prepared by licensed 503A compounding pharmacies, which follow the same dosing schedule and escalation protocol as brand-name Ozempic. The medication is bioidentical—your body processes it the same way and achieves the same weekly injection routine and dose titration. Compounded semaglutide is available to all 50 states without insurance and starts at $149 per month, making the same clinical dosing strategy accessible at a lower cost.
The key advantage of choosing compounded semaglutide through PlexusDx is affordability and convenience without sacrificing the proven dosing science. Your dose may need to go up as you progress, but your monthly price remains flat regardless of dose level. HSA and FSA accounts cover compounded semaglutide, and PlexusDx does not charge membership fees or require insurance approval.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the starting dose of semaglutide, and when do I increase it?
Semaglutide starts at 0.25 mg injected once weekly. After four weeks, your dose increases by 0.25 mg increments each month until you reach your target maintenance dose, typically 1.7 mg or 2.4 mg per week. PlexusDx tracks your progress and adjusts your escalation schedule based on your response and tolerance.
How long does it take to reach the full weight-loss dose of semaglutide?
Most patients reach their effective maintenance dose within 16 to 20 weeks of starting semaglutide. This gradual approach minimizes side effects and allows your body to adapt. Once you stabilize at your target dose, you remain on that same injection every seven days.
Can I skip weeks or take semaglutide less frequently than once per week?
No—semaglutide must be taken exactly once per week for the medication to maintain therapeutic levels and continue suppressing appetite and supporting weight loss. Skipping doses or spacing injections further apart can reduce effectiveness and cause rebound hunger. Consistency is essential to PlexusDx success.
Does PlexusDx compounded semaglutide use the same dosing schedule as Ozempic?
Yes, PlexusDx compounded semaglutide follows identical dosing—0.25 mg weekly starting dose with 0.25 mg increases every four weeks. Compounded semaglutide is bioidentical to brand-name Ozempic and costs less, starting at $149 per month with no your dose may need to go up - your price won't increases.
How does the Precision Peptide Genetic Test help with my semaglutide dosing?
PlexusDx's Precision Peptide Genetic Test analyzes your GLP1R and GIPR gene variants to predict how your body processes semaglutide and what maintenance dose you may need. This $99 add-on test (after your first month of treatment) personalizes your dose plan based on 14 peptide pathways and 150+ genetic insights, optimizing your weight loss outc...
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Which GLP-1 Are Approved for Weight Loss?
Lipo B Tirzepatide Stack — How It Works | TrimRx